Drugs that contain Dexamethasone
1. Drug name - DEXTENZA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9254267 | OCULAR THERAPEUTIX | Composite hydrogel drug delivery systems |
Sep, 2024
(1 year, 11 months from now) | |
| US8563027 | OCULAR THERAPEUTIX | Drug delivery through hydrogel plugs |
Feb, 2030
(7 years from now) | |
| US8409606 | OCULAR THERAPEUTIX | Drug delivery through hydrogel plugs |
May, 2030
(7 years from now) | |
Treatment: Dextenza is approved for the treatment of ocular pain following ophthalmic surgery
Dosage: INSERT;OPHTHALMIC
| Strength | Dosage | Availability |
|---|---|---|
| 0.4MG | INSERT;OPHTHALMIC | Prescription |
2. Drug name - DEXYCU KIT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6960346 | EYEPOINT PHARMS | Vehicles for delivery of biologically active substances |
Jul, 2023
(8 months from now) | |
| US10799642 | EYEPOINT PHARMS | Dose guides for injection syringe |
May, 2032
(9 years from now) | |
| US10028965 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(11 years from now) | |
| US10159683 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(11 years from now) | |
| US10022502 | EYEPOINT PHARMS | Dose guides for injection syringe |
Jun, 2034
(11 years from now) | |
Treatment: Treatment of postoperative inflammation
Dosage: SUSPENSION;INTRAOCULAR
| Strength | Dosage | Availability |
|---|---|---|
| 9% | SUSPENSION;INTRAOCULAR | Prescription |
3. Drug name - HEMADY
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10537585 | DEXCEL PHARMA | Compositions comprising dexamethasone |
Dec, 2037
(15 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| 20MG | TABLET;ORAL | Prescription |
4. Drug name - OZURDEX
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8506987 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US10702539 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US9192511 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US10076526 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US8034370 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US8034366 | ALLERGAN | Ocular implant made by a double extrusion process |
Jan, 2023
(3 months from now) | |
| US6899717 | ALLERGAN | Methods and apparatus for delivery of ocular implants |
Nov, 2023
(1 year, 28 days from now) | |
Treatment: Treatment of macular edema; treatment of uveitis; Treatment of diabetic macular edema; treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo); treatment of non-infectious uveitis affecting the posterior segment of the eye; Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex
Dosage: IMPLANT;INTRAVITREAL
| Strength | Dosage | Availability |
|---|---|---|
| 0.7MG | IMPLANT;INTRAVITREAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.